In a regulatory filing the company said "it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA)."from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XnV7pF
via IFTTT
0 comments:
Post a Comment